Scientists model 'true prevalence' of COVID-19 throughout pandemic
(University of Washington) University of Washington scientists have developed a statistical framework that incorporates key COVID-19 data -- such as case counts and deaths due to COVID-19 -- to model the true prevalence of this disease in the United States and individual states. Their approach projects that in the U.S. as many as 60% of COVID-19 cases went undetected as of March 7, 2021, the last date for which the dataset they employed is available. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 26, 2021 Category: Infectious Diseases Source Type: news

Safety of second dose of mRNA COVID-19 vaccines after first-dose allergic reactions
(JAMA Network) What The Study Did: Researchers examined the safety of the second dose of the Pfizer-BioNTech or Moderna COVID-19 vaccines in patients who experienced an allergic reaction to the first dose. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 26, 2021 Category: Infectious Diseases Source Type: news

Anticipate a resurgence of respiratory viruses in young children
(Canadian Medical Association Journal) Canada should anticipate a resurgence of a childhood respiratory virus as COVID-19 physical distancing measures are relaxed, authors warn in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.210919. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 26, 2021 Category: Infectious Diseases Source Type: news

New insights into immune responses to malaria
(Walter and Eliza Hall Institute) Advanced technologies have been used to solve a long-standing mystery about why some people develop serious illness when they are infected with the malaria parasite, while others carry the infection asymptomatically. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 23, 2021 Category: Infectious Diseases Source Type: news

UMass Amherst grad student awarded fellowship for food allergy research
(University of Massachusetts Amherst) University of Massachusetts Amherst food science Ph.D. candidate Cassandra Suther has received a prestigious predoctoral fellowship of $180,000 from the U.S. Department of Agriculture's National Institute of Food and Agriculture (USDA-NIFA) to study the effect of norovirus on the development and severity of food allergies. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 23, 2021 Category: Infectious Diseases Source Type: news

New 'atlas' charts how antibodies attack spike protein variants
(Brigham and Women's Hospital) Now, researchers from Brigham and Women's Hospital and collaborators have created an " atlas " that charts how 152 different antibodies attack a major piece of the SARS-CoV-2 machinary, the spike protein, as it has evolved since 2020. Their study, published in Cell, highlights antibodies that are able to neutralize the newer strains, while identifying regions of the spike protein that have become more resistant to attack. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 23, 2021 Category: Infectious Diseases Source Type: news

Why do some people get severe COVID-19? The nose may know
(Boston Children's Hospital) The body's first encounter with the coronavirus happens in the nose and throat. New work in Cell suggests that responses in this early battleground help determine who will develop severe COVID-19 and who will have only mild or no illness. It used single-cell RNA sequencing of all the cell types recovered from nasal swabs of people with and without COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 23, 2021 Category: Infectious Diseases Source Type: news

Advantages of intranasal vaccination against SARS-CoV-2
(University of Alabama at Birmingham) There are many reasons that an intranasal vaccine against the SARS-CoV-2 virus would be helpful in the fight against COVID-19 infections, University of Alabama at Birmingham immunologists Fran Lund, Ph.D., and Troy Randall, Ph.D., write in a viewpoint article in the journal Science. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 23, 2021 Category: Infectious Diseases Source Type: news

Early antiviral response in the nose may determine the course of COVID-19
(Broad Institute of MIT and Harvard) How early is the course of COVID-19, mild or severe, determined? In Cell, researchers examined nasal cells sampled from patients at the time of diagnosis, looking for differences between those who developed severe disease and those who experienced a mild illness. Cells from patients who developed severe COVID-19 exhibited a more muted antiviral response. If the early stages of infection can determine disease severity, it opens a path for scientists to develop early therapeutic interventions. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 23, 2021 Category: Infectious Diseases Source Type: news

AZ heroes study awarded $15M to continue, expand evaluation of COVID-19 immunity
(University of Arizona Health Sciences) A research study that started by analyzing COVID-19 immunity and vaccine effectiveness in frontline workers is broadening to include children. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 23, 2021 Category: Infectious Diseases Source Type: news

Less-sensitive COVID-19 tests may still achieve optimal results if enough people tested
(PLOS) A computational analysis of COVID-19 tests suggests that, in order to minimize the number of infections in a population, the amount of testing matters more than the sensitivity of the tests that are used. Philip Cherian and Gautam Menon of Ashoka University in Sonipat, India, and Sandeep Krishna of the National Centre for Biological Sciences TIFR, Bangalore, India, present their findings in the open-access journal PLOS Computational Biology. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 22, 2021 Category: Infectious Diseases Source Type: news

Global warming may limit spread of dengue fever, new research finds
(Penn State) Infection with dengue virus makes mosquitoes more sensitive to warmer temperatures, according to new research led by Penn State researchers. The team also found that infection with the bacterium Wolbachia, which has recently been used to control viral infections in mosquitoes, also increases the thermal sensitivity of the insects. The findings suggest that global warming could limit the spread of dengue fever but could also limit the effectiveness of Wolbachia as a biological control agent. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 22, 2021 Category: Infectious Diseases Source Type: news

Prostate cancer treatment among black, white patients during pandemic
This study included 647 patients with untreated nonmetastatic prostate cancer (269 patients during the pandemic and 378 from before the pandemic). During the initial COVID-19 lockdown, only 1% of Black men underwent prostatectomy, while 26% of white patients did. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 22, 2021 Category: Infectious Diseases Source Type: news

COVID-19: Patients with malnutrition may be more likely to have severe outcomes
(Scientific Reports) Adults and children with COVID-19 who have a history of malnutrition may have an increased likelihood of death and the need for mechanical ventilation, according to a study published in Scientific Reports. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 22, 2021 Category: Infectious Diseases Source Type: news

New insights into uncontrolled inflammation in COVID-19 patients
(Queen Mary University of London) Research led by Queen Mary University of London provides new insight into the mechanisms that lead to uncontrolled inflammation in COVID-19 patients. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 22, 2021 Category: Infectious Diseases Source Type: news

Interaction identified between SARS-CoV-2 and unusual RNA structures in human cells
(Institut Pasteur) Replication of SARS-CoV-2, the virus responsible for COVID-19, depends on a series of interactions between viral proteins and different cellular partners such as nucleic acids (DNA or RNA). Characterizing these interactions is crucial to elucidate the process of viral replication and identify new drugs for treating COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 22, 2021 Category: Infectious Diseases Source Type: news

Association between COVID-19 exposure, self-reported compliance with public health guidelines among essential employees at an institution of higher education
This study at an institution of higher education in Colorado evaluated the association between self-reported protective behaviors and how common SARS-CoV-2 infection was among essential in-person employees during the first six months of the COVID-19 pandemic in the United States. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 21, 2021 Category: Infectious Diseases Source Type: news

Existing drug is shown to inhibit SARS-CoV-2 virus
(University of Chicago) A new University of Chicago study has found that the drug masitinib may be effective in treating COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 21, 2021 Category: Infectious Diseases Source Type: news

Study links vaccine immune response to age
(Oregon Health& Science University) Older people appear to have fewer antibodies against the novel coronavirus, a new laboratory study from Oregon Health& Science University suggests. With vaccine uptake slowing in Oregon and across United States, researchers say their findings underscore the importance of promoting vaccinations in local communities. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 21, 2021 Category: Infectious Diseases Source Type: news

Long COVID and severe COVID-19 infections associated with Epstein-Barr virus reactivation
(World Organization) Two recently published studies indicate Epstein-Barr virus (EBV) reactivation may play a role both in the development of long COVID symptoms, as well as severe COVID-19 cases. A study in Pathogens found over 73% of COVID-19 patients who were experiencing long Covid symptoms were also positive for EBV reactivation. A study in Scientific Reports by Nature found EBV reactivation was also associated with COVID-19 severity. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 21, 2021 Category: Infectious Diseases Source Type: news

Heart-related test results may indicate risk of death in patients with COVID-19
(Wiley) New research published in the European Journal of Clinical Investigation identifies cardiovascular test results that might help to identify patients hospitalized with COVID-19 who face an especially high risk of dying. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 21, 2021 Category: Infectious Diseases Source Type: news

How has the COVID-19 pandemic affected our dreams?
(Wiley) The COVID-19 pandemic has strongly impacted our sleep and dream activity. In a recent study published in the Journal of Sleep Research, people had a higher number of awakenings, a harder time falling asleep, higher dream recall, and more lucid dreams during lockdown than after lockdown. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 21, 2021 Category: Infectious Diseases Source Type: news

Which students are at most risk of mental health problems during COVID-19 lockdowns?
(Wiley) A new study published in JCPP Advances has compared the wellbeing of UK students who remained at home for schooling during the first lockdown period of the COVID-19 pandemic with those who accessed school in person. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 21, 2021 Category: Infectious Diseases Source Type: news

How readily does COVID-19 spread on school buses?
(Wiley) Although in-school transmission of COVID-19 among K-12 students is low when safeguards are in place, the risk of acquiring COVID-19 during school bus transportation is unclear. A study published in the Journal of School Health reports on the bus transport experience of an independent school in Virginia. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 21, 2021 Category: Infectious Diseases Source Type: news

The Lancet: 1.5 million children worldwide have lost parent, grandparent, caregiver due to COVID-19
(The Lancet) An estimated 1.5 million children worldwide have experienced the death of a parent, custodial grandparent, or other relative who cared for them, as a result of COVID-19, according to a new study published in The Lancet. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 20, 2021 Category: Infectious Diseases Source Type: news

More than 1.5M children lost a primary or secondary caregiver due to the COVID-19 pandemic
(NIH/National Institute on Drug Abuse) More than 1.5 million children around the world are estimated to have lost at least one parent, custodial grandparent, or grandparent who lived with them due to death related to COVID-19 during the first 14 months of the pandemic, according to a study published today in The Lancet. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 20, 2021 Category: Infectious Diseases Source Type: news

COVID-19 news from Annals of Internal Medicine
(American College of Physicians) 1. Currently used SARS-CoV-2 vaccines more than 95% effective in preventing confirmed infection ; 2. Having sickle cell disease quadruples risk for COVID-19-related hospitalization and doubles risk for COVID-19-related death. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 20, 2021 Category: Infectious Diseases Source Type: news

No horsing around: super-fast Hendra test developed
(University of Queensland) University of Queensland vets are diagnosing the deadly Hendra virus in horses faster than ever, developing a diagnostic point-of-care kit that can detect the pathogen in under an hour, rather than days. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 20, 2021 Category: Infectious Diseases Source Type: news

CEPI and IVI collaborate on clinical research to expand access to COVID-19 vaccines in Africa
(International Vaccine Institute) The Coalition for Epidemic Preparedness Innovations (CEPI) and the International Vaccine Institute (IVI) today announced a new programme of clinical research which aims to expand access to COVID-19 vaccines in Africa. CEPI will provide funding of up to $12.7m to the Expanding Access and Delivery of COVID-19 Vaccines in Africa (ECOVA) consortium led by IVI to carry out clinical trials of Sinopharm's BBIBP-CorV vaccine which will support the expanded use of the vaccine on the African continent. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 20, 2021 Category: Infectious Diseases Source Type: news

Learning from the pandemic to improve healthcare
(University of Southern California) The USC Viterbi School of Engineering, The Gehr Family Center at the Keck School of Medicine at USC, and the USC Price School of Public Policy are jointly hosting four 2-hour online sessions on learning from the pandemic to improve healthcare. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 20, 2021 Category: Infectious Diseases Source Type: news

Children's National Hospital and NIAID launch study on long-term impacts of COVID-19 and MIS-C
(Children's National Hospital) Up to 2,000 children and young adults will be enrolled in a study from Children's National Hospital in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) that will examine the long-term effects of COVID-19 and multisystem inflammatory syndrome in children (MIS-C) after these patients have recovered from a COVID-19 infection. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 20, 2021 Category: Infectious Diseases Source Type: news

Take your best shot: Which SARS-CoV-2 vaccine should I get, if any?
(University of Cincinnati) Researchers at the University of Cincinnati College of Medicine have developed a computerized decision analytic model to compare projected outcomes of three vaccine strategies: a patient opts for a messenger RNA vaccine, a patient decides to get an adenovirus vector vaccine or the patient simply forgoes a vaccine altogether. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 20, 2021 Category: Infectious Diseases Source Type: news

SARS-CoV-2: Achilles' heel of viral RNA
(Goethe University Frankfurt) Certain regions of the SARS-CoV-2 genome might be a suitable target for future drugs. This is what researchers at Goethe University, together with their collaborators in the international COVID-19-NMR consortium, have now discovered. With the help of dedicated substance libraries, they have identified several small molecules that bind to certain areas of the SARS-CoV-2 genome that are almost never altered by mutations. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 20, 2021 Category: Infectious Diseases Source Type: news

The environmental toll of disposable masks
(Massachusetts Institute of Technology) The high monetary cost and environmental toll of disposable N95 masks could be dramatically cut by adopting reusable masks, according to an MIT study that calculated the financial and environmental cost of several different mask usage scenarios. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 20, 2021 Category: Infectious Diseases Source Type: news

WVU-led team, through NIH grant, ramps up COVID-19 testing in rural West Virginia
(West Virginia University) With help from grant funding, the West Virginia Clinical and Translational Science Institute based at West Virginia University has expanded COVID-19 testing in partnership with the state's Department of Health and Human Resources and the National Guard and primary care clinics in the West Virginia Practice-Based Research Network. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 20, 2021 Category: Infectious Diseases Source Type: news

Study refutes suspicion that dengue increases risk of microcephaly associated with zika
(Funda ç ã o de Amparo à Pesquisa do Estado de S ã o Paulo) Researchers compared data for pregnant women in two cities who were infected by zika virus in 2015-16. Factors that influenced the risk of fetal malformation were the high zika attack rate in the area and being infected in the first trimester of pregnancy. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 20, 2021 Category: Infectious Diseases Source Type: news

Public trust in CDC, FDA, and Fauci holds steady, survey shows
(Annenberg Public Policy Center of the University of Pennsylvania) Top U.S. health agencies retain the trust of the vast majority of the American public, as does Dr. Anthony Fauci, according to a new survey from the Annenberg Public Policy Center. Public confidence has grown in the safety and effectiveness of vaccines to prevent Covid-19. But people who say they rely on conservative media have less confidence in Fauci and are more likely to accept misinformation and conspiracy theories. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 20, 2021 Category: Infectious Diseases Source Type: news

Strong immune response underlies acute kidney injury related to COVID-19
(Mayo Clinic) Mayo Clinic researchers have found that acute kidney injury associated with COVID-19 resembles sepsis-caused kidney injury, and the immune response triggered by the infection plays a pivotal role.The findings, published in Mayo Clinic Proceedings, also suggest that mitochondrial dysfunction -- a loss of function in cellular energy production -- is commonly found in kidney injury related to COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 20, 2021 Category: Infectious Diseases Source Type: news

Antibiotic prescriptions for kids plummet during pandemic
(Michigan Medicine - University of Michigan) Study finds medications prescribed for children dropped by more than a quarter during the first eight months of the pandemic compared to the previous year, with the steepest declines in infection-related medicines like antibiotics and cough-and-cold drugs. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 20, 2021 Category: Infectious Diseases Source Type: news

Public health summer program increases STEM career interests in high schoolers
(Rutgers University) High school students who participated in summer programs about public health increased their interest in pursuing careers in science, technology, engineering and mathematics (STEM), according to a Rutgers study. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 19, 2021 Category: Infectious Diseases Source Type: news

Mayo research provides insights into high-risk younger demographics for severe COVID-19
(Mayo Clinic) Using data from 9,859 COVID-19 infections, Mayo Clinic researchers have new insights into risk factors for younger populations, some of which differ significantly from their older counterparts. People younger than 45 had a greater than threefold increased risk of severe infection if they had cancer or heart disease, or blood, neurologic or endocrine disorders, the research found. These associations were weaker in older age groups. The study was published in Mayo Clinic Proceedings. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 19, 2021 Category: Infectious Diseases Source Type: news

SARS-CoV-2 spike mutation L452R evades human immune response and enhances infectivity
(Kumamoto University) An international team of researchers led by Kumamoto and Tokyo Universities (Japan) have shown that the L452R mutation of the SARS-CoV-2 spike protein, which is common to two variants (Epsilon and Delta), is involved in cellular immunity evasion via the human leukocyte antigen (HLA) A24, and enhances viral infectivity. HLA-A24 is one of the most prominent HLA-class I alleles, especially in East/Southeast Asian populations, which might make them particularly vulnerable to variants with the mutation. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 19, 2021 Category: Infectious Diseases Source Type: news

Rapid screening, face masks may prevent SARS-CoV-2 transmission at indoor mass-gathering events
(American College of Physicians) An observational study in Barcelona, Spain found that implementation of same-day rapid screening, use of face masks, and improved ventilation was associated with very low rates of SARS-CoV-2 transmission at an indoor mass-gathering live concert without physical distancing. The brief research report is published in Annals of Internal Medicine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 19, 2021 Category: Infectious Diseases Source Type: news

COVID-19-related immigration concerns among Latinx immigrants in US
(JAMA Network)What The Study Did:These results suggest that substantial proportions of Latinximmigrants have immigration concernsabout engaging in COVID-19-relatedtesting, treatment and contact tracing. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 19, 2021 Category: Infectious Diseases Source Type: news

COVID-19 antibodies persist at least nine months after infection
(Imperial College London) Testing of an entire Italian town shows antibody levels remain high nine months after SARS-CoV-2 infection, whether symptomatic or asymptomatic. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 19, 2021 Category: Infectious Diseases Source Type: news

USC study shows male-female differences in immune cell function
(University of Southern California) How a type of white blood cell, called neutrophils, responds to pathogens varies greatly between the sexes and with age in a mouse study at USC. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 19, 2021 Category: Infectious Diseases Source Type: news

Deconstructing the infectious machinery of SARS-CoV-2
(DOE/Lawrence Berkeley National Laboratory) Scientists from three national labs have published a comprehensive study that - alongside other recent, complementary studies of coronavirus proteins and genetics - represents the first step toward developing treatments for COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 19, 2021 Category: Infectious Diseases Source Type: news

Novel coronavirus discovered in British bats
(University of East Anglia) A coronavirus related to the virus that causes Covid-19 in humans has been found in UK horseshoe bats. However, there is no evidence that this novel virus has been transmitted to humans, or that it could in future, unless it mutates. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 19, 2021 Category: Infectious Diseases Source Type: news

RedHill Biopharma announces last patient out for phase 2/3 COVID-19 study of oral Opaganib
(RedHill Biopharma) RedHill Biopharma Ltd. (Nasdaq: RDHL), a specialty pharma company that is a leader in the development of novel oral therapies for COVID-19, today announced that all treatment and follow-up has now been completed in the 475-patient global Phase 2/3 study with opaganib (ABC294640) in patients hospitalized with severe COVID-19 pneumonia (NCT04467840). Top-line results are expected in the coming weeks. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 19, 2021 Category: Infectious Diseases Source Type: news